Utah Medical Products, Inc. Announces Quarterly Dividend
Rhea-AI Summary
Utah Medical Products (NASDAQ:UTMD) announced a quarterly cash dividend of $.29 per share, reflecting a 1.8% increase from the previous year. The dividend will be payable on April 5, 2022, to shareholders of record as of March 18, 2022. The company is recognized for its development and marketing of specialty medical devices, particularly focused on women's health and pediatric care, serving clinicians in over a hundred countries. For further details, visit www.utahmed.com.
Positive
- Quarterly cash dividend of $.29 per share represents a 1.8% increase from the previous year.
- Continued commitment to returning value to shareholders through consistent dividend payments.
Negative
- None.
News Market Reaction – UTMD
In the trading session that priced this news, UTMD gained 2.29%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, UT / ACCESSWIRE / February 8, 2022 / Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents ($.29) per share of common stock payable on April 5, 2022 to shareholders of record at the close of business on March 18, 2022. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
CONTACT
Crystal Rios
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View source version on accesswire.com:
https://www.accesswire.com/687702/Utah-Medical-Products-Inc-Announces-Quarterly-Dividend